Read More Pharma Industry News RemeGen’s RC88 shows promising results in Phase I/II study for advanced solid tumors RemeGen Co., Ltd., a leader in biopharmaceutical innovation based in China, has unveiled promising results from its Phase… byPallavi MadhirajuJune 4, 2024